A multiple dosing (14 days) study to assess efficacy and safety of three dose levels of AZD7594, given once daily by inhalation, in patients with mild to moderate asthma

Trial Identifier: D3741C00003
Sponsor: AstraZeneca
NCTID:: NCT02479412
Start Date: June 2015
Primary Completion Date: February 2016
Study Completion Date: February 2016
Condition: Asthma; Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Bulgaria Sofia, Bulgaria, 1612
Germany Berlin, Germany, 10717
Germany Berlin, Germany, 10969
Germany Berlin, Germany, 14050
Germany Frankfurt, Germany, 60596
Germany Großhansdorf, Germany, 22927
Germany Hamburg, Germany, 22143
Germany Hamburg, Germany, 20354
Germany Lübeck, Germany, 23552
Germany Wiesbaden, Germany, 65187